Akero Therapeutics, Inc. (AKRO) Insider Trading

Name: Akero Therapeutics, Inc. (AKRO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Dec 9, 2025): Tomas J. Heyman (Director): Disposition to Issuer of 9,398 shares.

Get alerted when insiders trade AKRO

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta